GSK to lower drug prices to help poorer countries

Move to let patents lapse will allow cheaper generic versions to come on to the market without the threat of legal action GlaxoSmithKline is to make medicines more affordable in developing countries, including waiving patent protection for new drugs in the world's poorest nations. Britain's biggest drugmaker said it would not file patents for new medicines in the poorest countries, such as Afghanistan, Rwanda and Cambodia, allowing cheaper generic versions to come on to the market without the th...